Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Tamura

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
BMC Rheumatology|November 4, 2025
Disease phenotype and management of axial psoriatic arthritis in Japan compared with other regions, particularly other Asian countries: results of the ASAS-PerSpA studyHaruki Sawada, Mitsumasa Kishimoto, Kurisu Tada, et al.
Modern Rheumatology|August 25, 2023
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' studyMasayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
BMJ Open|May 8, 2024
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trialYasuhiro Homma, Takuma Yamasaki, Ken Tashiro, et al.
Modern Rheumatology|February 26, 2016
The synovial grade corresponding to clinically involved joints and a feasible ultrasound-adjusted simple disease activity index for monitoring rheumatoid arthritisYusuke Yamada, Michihiro Ogasawara, Misa Gorai, et al.
Clinical Rheumatology|July 21, 2011
Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritisMichihiro Ogasawara, Naoto Tamura, Michiaki Kageyama, et al.
Modern Rheumatology|August 9, 2024
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance studyNami Okamoto, Tatsuya Atsumi, Michiaki Takagi, et al.
Modern Rheumatology|December 22, 2025
Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping reviewMayu Shiomi, Tomoaki Higuchi, Mitsuhiro Akiyama, et al.
Modern Rheumatology|December 17, 2021
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare DatabaseKenji Nagasaka, Shinya Kaname, Koichi Amano, et al.
Modern Rheumatology|May 10, 2024
Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI)Kenta Misaki, Eiichi Tanaka, Eisuke Inoue, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2025
Cell-free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascitesYu Yamaji, Goh Murayama, Moeko Inoue, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
BMC Rheumatology|November 4, 2025
Disease phenotype and management of axial psoriatic arthritis in Japan compared with other regions, particularly other Asian countries: results of the ASAS-PerSpA studyHaruki Sawada, Mitsumasa Kishimoto, Kurisu Tada, et al.
Modern Rheumatology|August 25, 2023
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' studyMasayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
BMJ Open|May 8, 2024
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trialYasuhiro Homma, Takuma Yamasaki, Ken Tashiro, et al.
Modern Rheumatology|February 26, 2016
The synovial grade corresponding to clinically involved joints and a feasible ultrasound-adjusted simple disease activity index for monitoring rheumatoid arthritisYusuke Yamada, Michihiro Ogasawara, Misa Gorai, et al.
Clinical Rheumatology|July 21, 2011
Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritisMichihiro Ogasawara, Naoto Tamura, Michiaki Kageyama, et al.
Modern Rheumatology|August 9, 2024
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance studyNami Okamoto, Tatsuya Atsumi, Michiaki Takagi, et al.
Modern Rheumatology|December 22, 2025
Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping reviewMayu Shiomi, Tomoaki Higuchi, Mitsuhiro Akiyama, et al.
Modern Rheumatology|December 17, 2021
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare DatabaseKenji Nagasaka, Shinya Kaname, Koichi Amano, et al.
Modern Rheumatology|May 10, 2024
Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI)Kenta Misaki, Eiichi Tanaka, Eisuke Inoue, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 15, 2025
Cell-free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascitesYu Yamaji, Goh Murayama, Moeko Inoue, et al.
Pageof 20